(Q73181590)
Statements
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape (English)
B Escudier
C Chevreau
C Lasset
J Y Douillard
M Fabbro
A Caty
J F Rossi
P Viens
J P Bergerat
J Savary